Manufacturing: Page 7
-
PharmaVoice Team/PharmaVoice
Tapping Into the Power by Getting Personal
More and more patients are using Facebook, YouTube, Twitter, and other social media outlets to discuss their health and treatments with peers and caregivers. Social media tools have become an effective way to expand reach, foster engagement, and increase access to credible, science-based health m...
By PharmaVoice Team • April 25, 2011 -
PharmaVoice Team/PharmaVoice
Creating a Personalized Medicine Strategy
Considered broadly, healthcare is personal. The goal of medical practitioners has always been to get the right drug to the right person at the right time at the right dose. But now industry experts say personalized medicine is at a tipping point as a multitude of factors converge, including advan...
By Denise Myshko • April 25, 2011 -
Explore the Trendline➔
Stock via Getty Images
TrendlineArtificial intelligence & machine learning
After years of excited buzz around the potential of artificial intelligence and machine learning, pharma has begun to realize the true implications and potential value of these technologies.
By PharmaVoice staff -
PharmaVoice Team/PharmaVoice
Last Word
John Gargiulo, Daiichi Sankyo’s new President and CEO, discusses the future opportunities for the company and the industry. Keeping the Patient Front and Center Last Word PV: What are your goals for Daiichi Sanyko? Gargiulo: The healthcare industry is currently experiencing unprecedented challeng...
By PharmaVoice Team • April 25, 2011 -
PharmaVoice Team/PharmaVoice
Privyet! Russia: Growth and Opportunity
With its promise of expansion, its population of around 140 million potential customers, and a pool of highly qualified staff, Russia has long been recognized as an important market for pharmaceutical companies. The pharma market in Russia has shown stable annual growth of 13% to 20% for several ...
By Kim Ribbink • March 28, 2011 -
PharmaVoice Team/PharmaVoice
Talent Pool
Pharmaceutical POOL Steve FRY Dr. Sue MAHONY Lilly Announces Leadership Shifts Lilly has promoted Steve Fry to senior VP of human resources and diversity. Mr. Fry was previously VP of human resources for two of Lilly’s business areas, biomedicines and emerging markets. Mr. Fry succeeds Sue Mahony...
By PharmaVoice Team • March 28, 2011 -
PharmaVoice Team/PharmaVoice
Thought Leaders
Ryan Abbate. President, Pacific Communications, a healthcare communications agency that offers strategic and tactical communications solutions. For more information, visit pacific-com.com. Edward Abrahams, Ph.D. President,The Personalized Medicine Coalition, which brings together the academ...
By PharmaVoice Team • March 7, 2011 -
PharmaVoice Team/PharmaVoice
Outsourcing: The Time is Right
The recent world economic events have set the stage for the shape of the industry going forward. “As market conditions evolve, pharma companies are reducing their infrastructures and costs, resulting in a stronger reliance on vendors to meet trial objectives, timelines, and budgets," says Jim DeS...
By PharmaVoice Team • March 7, 2011 -
PharmaVoice Team/PharmaVoice
What's New
Through its recent acquisition of MedPage Today, a news organization serving healthcare professionals, Everyday Health has added a significant offering for healthcare professionals to its portfolio of consumer health information brands. MedPage provides healthcare professionals with peer-reviewed...
By PharmaVoice Team • March 3, 2011 -
PharmaVoice Team/PharmaVoice
Marketing: What Was Old Is New Again
Patients, ROI, an evolving landscape, and so on have been on the minds of marketers for years; but today success will lie in new solutions and approaches to overcome these chronic issues through innovative technologies and adaptive strategies. Patients Take Center Stage Our experts tell us that t...
By PharmaVoice Team • Nov. 10, 2010 -
PharmaVoice Team/PharmaVoice
PharmaTrax
Sales, Marketing, and R&D Trends from Industry Analysts Featured Briefs: Accurate, Rapid Diagnosis Key to Developing Effective Infectious Disease Therapies MSLs Are Increasingly Important for Thought Leader Relationships Pharma Companies Increasing Outsource Manufacturing, Supply Chain IT ...
By PharmaVoice Team • Sept. 28, 2010 -
PharmaVoice Team/PharmaVoice
Talent Pool
Pharmaceutical POOL Lonnel COATS Eisai Names CEO for U.S. Subsidiary Eisai Inc., a U.S. subsidiary of Japan’s Eisai Co., has promoted Lonnel Coats to president and CEO, from president and chief operating officer. In addition, Mr. Coats has been appointed senior VP of Eisai Co.’s pharmaceuticals b...
By PharmaVoice Team • Aug. 26, 2010 -
PharmaVoice Team/PharmaVoice
Who's On The List by Section
The Commanders & Chiefs Johanna Allston, Ph.D. – bioCapture Vicente Anido Jr., Ph.D. – ISTA Pharmaceuticals Mara Aspinall – On-Q-ity Glenn Bilawsky – i3 Jay Bolling – Roska Healthcare David Brennan – AstraZeneca Nick Colucci – Publicis Healthcare – Communications Group Lynnette Cooke – Kantar...
By PharmaVoice Team • July 29, 2010 -
PharmaVoice Team/PharmaVoice
The CHANGE AGENTS
It was apparent from the start of his career that Leo Francis, Ph.D., was a leader in the making. From his early days in the industry, Dr. Francis’ professionalism and inexorable drive for excellence in all aspects of his work have shone through. His achievements have led to extraordinary progre...
By PharmaVoice Team • July 28, 2010 -
PharmaVoice Team/PharmaVoice
Talent Pool
Pharma POOL Dr. Mike BURGESS, Roche Dr. Mikael DOLSTEN, Pfizer Kenneth FRAZIER, Merck Adam SCHECHTER, Merck Biotechnology POOL Robert BRADWAY, Amgen Dr. Henry LI, Kylin Therapeutics Kenneth MOCH, Chimerix Dr. George PAINTER, Chimerix Dr. Thomas PITLER, Chimerix Biopharmaceutical POOL Dr. John ALA...
By PharmaVoice Team • July 28, 2010 -
PharmaVoice Team/PharmaVoice
Talent Pool
Pharma POOL Mark BOOTH Takeda Pharmaceuticals North America Names President Takeda Pharmaceuticals North America Inc. (TPNA), a wholly owned subsidiary of Takeda Chemical Industries Ltd., has restructured its senior executive team and named Mark Booth president. Mr. Booth, an 18year veteran of th...
By PharmaVoice Team • Jan. 14, 2010 -
PharmaVoice Team/PharmaVoice
Practical Medicine:
Diagnosing the condition DERMAN. Insurance and reimbursement are two big challenges. Part of the problem is that reimbursement rates have dropped, thus physicians need to see more patients, more efficiently, in the same period of time to cover overhead. This is true even in an academic environmen...
By PharmaVoice Team • Jan. 14, 2010 -
PharmaVoice Team/PharmaVoice
Xyrem: Awakenings
PharmaVOICE approved for treating cataplexy. Of the esti mated 140,000 Americans who suffer from narcolepsy, between 60% and 90% experience cataplexy. Orphan Medical Inc. developed Xyrem under the FDA’s Orphan Drug Act of 1983, which provides market exclusivity to companies that develop products ...
By PharmaVoice Team • Jan. 14, 2010 -
PharmaVoice Team/PharmaVoice
E-Media
NEW ELECTRONIC AND WEBBASED APPLICATIONS, SITES, AND TECHNOLOGIES The Rosetta Luminator system, a clientserver bioinformatics system for storing and analyzing microarray data, has been launched by Rosetta Biosoftware and Agilent Technologies Inc. The geneexpression data analysis solution was deve...
By PharmaVoice Team • Jan. 13, 2010 -
PharmaVoice Team/PharmaVoice
Manufacturing for Bio Capacity
George Coleman President, Biomedex Inc., Spokane, Wash.; Biomedex specializes in a broad spectrum of contract manufacturing services for bio- pharmaceutical clients, from regulatory compliance to aseptic filling, to validation, to cleanroom sanitizing agents, to quality assurance, to component cl...
By Denise Myshko • Jan. 11, 2010 -
PharmaVoice Team/PharmaVoice
Contents
In Every Issue 3 Letter from the Editor 8 Upfront A brief review of industry news at press time 36 Pharma Trax Sales, marketing, and R&D trends from industry analysts 40 What’s New New healthcare-related products, services, and companies 42 E-Media New electronic and Web-based applications, s...
By PharmaVoice Team • Dec. 28, 2009 -
PharmaVoice Team/PharmaVoice
Emerging Markets Poised for Growth
Emerging markets are growing in size and in importance for drug developers. Countries outside the traditional markets of the United States, Europe, and Japan are revamping their regulatory and legal systems and reforming their healthcare systems, and they are expected to contribute more to the gl...
By PharmaVoice Team • Nov. 10, 2009 -
PharmaVoice Team/PharmaVoice
Supply Chain Strategies
Companies need to evaluate their business through their value streams rather than by individual processes or components. ccording to Bob Silvers, managing director, at SSA & Co., by applying the rigors of Lean Six Sigma to underperforming areas, pharmaceutical companies can completely transfo...
By Denise Myshko • Nov. 10, 2009 -
PharmaVoice Team/PharmaVoice
Who's on the List by Company
Acadia Pharmaceuticals Inc. John Kaiser 68 Acorda Therapeutics Inc. Ron Cohen, M.D. 39 Alnylam Pharmaceuticals John Maraganore, Ph.D. 24 AMR Research Hussain Mooraj 107 Amylin Pharmaceuticals Joseph Martinez 76 Astellas Pharma US Charlotte Berlin 64 AVEO Pharmaceuticals Inc. Tuan Ha-Ngoc 20 Avid ...
By PharmaVoice Team • July 29, 2009 -
PharmaVoice Team/PharmaVoice
Contents
12 Commanders & Chiefs These inspirational leaders take charge of their companies’ growth and success by providing a clear vision, developing innovative solutions, and making the tough decisions. 34 The Entrepreneurs Forward-thinking, committed, and dedicated are just the tip of the adjective...
By PharmaVoice Team • July 29, 2009 -
PharmaVoice Team/PharmaVoice
Letter from the Editor
The PharmaVOICE 100: 2009 PharmaVOICE is honored to bring you its fifth annual special issue celebrating 100 of the most inspiring individuals in the life-sciences industry. This issue, which is called the feel-good issue of the year, is packed with in-depth profiles showcasing the industry’s bes...
By Taren Grom • July 29, 2009
Previous
